Atlas Trials

Safety Study of a Cell Penetrating Peptide (p28) to Treat Solid Tumors That Resist Standard Methods of Treatment

Clinical trial NCT00914914 · COMPLETED

Trial details

NCT number
NCT00914914
Sponsor
Dr. Tapas K. Das Gupta
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Refractory Solid Tumors
Start date
2009-04-01
Primary completion
2011-04-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.